FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls
- 28 February 2005
- journal article
- editorial
- Published by Elsevier in Lung Cancer
- Vol. 47 (2) , 151-153
- https://doi.org/10.1016/j.lungcan.2003.09.027
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experienceAnnals of Oncology, 2004
- Preoperative chemoradiation approaches to locally advanced non-small-cell lung cancer: one man’s pride, another man’s burden?Annals of Oncology, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non–Small-Cell Lung CancerAnnals of Internal Medicine, 2003
- Guidelines on Treatment of Stage IIIB Non-small Cell Lung Cancer*Chest, 2003
- Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.Journal of Clinical Oncology, 1998
- Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scanEuropean Journal of Cardio-Thoracic Surgery, 1997
- Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.Radiology, 1994